nav-left cat-right
cat-right

RICT 2015 Drug Discovery and Selection – Jul...

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT) is pleased to invite you to Avignon on July 1-3, 2015, for the 51st edition of the International Conference on Medicinal Chemistry (RICT 2015). The scientific programme, which will include over 25 plenary lectures by internationally well-known scientists, will focus on “Drug Discovery and Selection – Understanding Targets and...

Biophysics in Drug Discovery 2015 June 9-12, 2015 ...

The use of biophysical techniques in drug discovery is rapidly increasing, and many pharmaceutical companies have set up in-house biophysical platforms to speed up the target-to-candidate process and improve the quality of small-molecule therapeutics through a better understanding of their interactions with their targets. However, biophysics for drug discovery had not yet been the subject of a dedicated conference: most of...

Bioheterocycles 2015 on June 7-11, 2015 Metz, Fran...

The XVI conference of this series will gather chemists from over the world, involved in the chemistry of heterocycles. The heterocycles in this case will generally be submitted to biological tests as well in medicine as in agriculture. The scientific programme will include plenary and invited lectures by top chemists in the field and will be completed by oral communications and poster presentations. The conference is intended...

Paediatric Clinical Trials 25th – 26th March...

A large number of medicines used in paediactric care have not been tested on children and are therefore used off lable or unlicensed. This absence of suitable authorised medicinal products to treat conditions in children is an issue that has been of concern for some time, and one that is increasingly coming to the fore. Returning for its ninth year as an industry leading event, SMI are proud to present the 9th annual...

Controlled Release Conference, 20th – 21st A...

As controlled release drug delivery systems continue to play an important role among the emerging areas of research in the treatment of diseases, this event will focus on specific topics looking at advances made in the field and how to overcome the challenges involved when developing controlled release formulations. Returning for its twelfth year and following on from the major success of previous events, SMi are proud to...

Adaptive Designs in Clinical Trials 20th April to ...

Prior to the approval of new drugs, substantial evidence of efficacy is required and safety brought through clinical trials. A massive decline in success rates in Phase II/III of clinical trials has resulted in only 1 in 10 drugs successfully passing  through these trials in the US. With increasing pressure to bring drugs quickly into the market and reduce the cost of drug development, the paradigms of drug dosage...
Page 10 of 30« First...89101112...2030...Last »